• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆血管性血友病因子水平对主要不良心血管事件的预后价值:系统评价和荟萃分析。

Prognostic value of plasma von Willebrand factor levels in major adverse cardiovascular events: a systematic review and meta-analysis.

机构信息

Laboratory of Microvascular Medicine, Medical Research Center, Shandong Provincial Qianfoshan Hospital, The First Affiliated Hospital of Shandong First Medical University, 16766 Jingshi Road, Jinan, 250014, Shandong, China.

Graduate School, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China.

出版信息

BMC Cardiovasc Disord. 2020 Feb 10;20(1):72. doi: 10.1186/s12872-020-01375-7.

DOI:10.1186/s12872-020-01375-7
PMID:32039706
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7011353/
Abstract

BACKGROUND

Prediction of major adverse cardiovascular events (MACEs) may offer great benefits for patients with coronary artery disease (CAD). Von Willebrand factor (vWF) is stored in endothelial cells and released into blood plasma upon vascular dysfunction. This meta-analysis was performed to evaluate the prognostic value of plasma vWF levels in CAD patients with MACEs.

METHODS

A total of 15 studies were included in this meta-analysis through the search in PubMed, Embase and CNKI. Data were collected from 960 patients who had MACEs after CAD and 3224 controls nested without the adverse events. The standard mean difference (SMD) and 95% confidence intervals (95% CI) were calculated using random-effects model.

RESULTS

The plasma vWF levels examined at 24 h and 48 h after admission were significantly higher in CAD patients with MACEs than those without. The pooled SMD among the MACEs group and the non-MACEs group was 0.55 (95% CI = 0.30-0.80, P < 0.0001) and 0.70 (95% CI = 0.27-1.13, P = 0.001), respectively. However, no significant difference was found in plasma vWF levels on admission between the two groups.

CONCLUSION

Plasma vWF level in CAD patients examined at 24 h and 48 h after admission might be an independent prognostic factor for MACE.

摘要

背景

预测主要不良心血管事件(MACE)可能会为冠心病(CAD)患者带来巨大益处。血管性血友病因子(vWF)储存于血管内皮细胞中,血管功能障碍时释放入血。本荟萃分析旨在评估 CAD 患者 MACE 时血浆 vWF 水平的预后价值。

方法

通过在 PubMed、Embase 和中国知网(CNKI)中检索,共纳入 15 项研究。共纳入 960 例发生 CAD 后发生 MACE 的患者和 3224 例无不良事件的对照患者。使用随机效应模型计算标准均数差(SMD)和 95%置信区间(95%CI)。

结果

入院后 24 h 和 48 h 检测的 CAD 患者血浆 vWF 水平明显高于无 MACE 患者。MACE 组和非 MACE 组的血浆 vWF 水平的合并 SMD 分别为 0.55(95%CI=0.30-0.80,P<0.0001)和 0.70(95%CI=0.27-1.13,P=0.001)。然而,两组入院时血浆 vWF 水平无显著差异。

结论

入院后 24 h 和 48 h 检测的 CAD 患者血浆 vWF 水平可能是 MACE 的独立预后因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9638/7011353/75ed4b249ff9/12872_2020_1375_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9638/7011353/ddc84863d56f/12872_2020_1375_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9638/7011353/736a78f076a2/12872_2020_1375_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9638/7011353/75ed4b249ff9/12872_2020_1375_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9638/7011353/ddc84863d56f/12872_2020_1375_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9638/7011353/736a78f076a2/12872_2020_1375_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9638/7011353/75ed4b249ff9/12872_2020_1375_Fig3_HTML.jpg

相似文献

1
Prognostic value of plasma von Willebrand factor levels in major adverse cardiovascular events: a systematic review and meta-analysis.血浆血管性血友病因子水平对主要不良心血管事件的预后价值:系统评价和荟萃分析。
BMC Cardiovasc Disord. 2020 Feb 10;20(1):72. doi: 10.1186/s12872-020-01375-7.
2
Association between brain-derived neurotrophic factor and von Willebrand factor levels in patients with stable coronary artery disease.稳定型冠状动脉疾病患者脑源性神经营养因子与血管性血友病因子水平之间的关联。
BMC Cardiovasc Disord. 2018 Feb 6;18(1):23. doi: 10.1186/s12872-018-0762-z.
3
Plasma levels of von Willebrand factor in type 2 diabetes patients with and without cardiovascular diseases: A meta-analysis.2 型糖尿病伴或不伴心血管疾病患者的血管性血友病因子血浆水平:一项荟萃分析。
Diabetes Metab Res Rev. 2020 Jan;36(1):e3193. doi: 10.1002/dmrr.3193. Epub 2019 Jul 7.
4
Prognostic value of von Willebrand factor in patients with atrial fibrillation: A meta-analysis.血管性血友病因子在房颤患者中的预后价值:一项荟萃分析。
Medicine (Baltimore). 2018 Jul;97(27):e11269. doi: 10.1097/MD.0000000000011269.
5
The relationship of circulating endothelial cells to plasma indices of endothelial damage/dysfunction and apoptosis in acute coronary syndromes: implications for prognosis.急性冠状动脉综合征中循环内皮细胞与内皮损伤/功能障碍及凋亡的血浆指标之间的关系:对预后的影响。
J Thromb Haemost. 2008 Nov;6(11):1841-50. doi: 10.1111/j.1538-7836.2008.03148.x. Epub 2008 Aug 28.
6
von Willebrand factor and its relevance to cardiovascular disorders.血管性血友病因子及其与心血管疾病的相关性。
Br Heart J. 1995 Dec;74(6):580-3. doi: 10.1136/hrt.74.6.580.
7
Biomarkers of endothelial dysfunction and outcomes in coronavirus disease 2019 (COVID-19) patients: A systematic review and meta-analysis.COVID-19 患者内皮功能障碍及结局的生物标志物:系统评价和荟萃分析。
Microvasc Res. 2021 Nov;138:104224. doi: 10.1016/j.mvr.2021.104224. Epub 2021 Jul 15.
8
Prognostic value of plasma von Willebrand factor-cleaving protease (ADAMTS13) antigen levels in patients with coronary artery disease.血浆血管性血友病因子裂解蛋白酶(ADAMTS13)抗原水平对冠心病患者的预后价值。
Thromb Haemost. 2010 Mar;103(3):623-9. doi: 10.1160/TH09-08-0568. Epub 2010 Feb 2.
9
Microalbuminuria, von Willebrand factor and fibrinogen levels as markers of the severity in COPD exacerbation.微量白蛋白尿、血管性血友病因子和纤维蛋白原水平作为慢性阻塞性肺疾病急性加重严重程度的标志物。
J Thromb Thrombolysis. 2008 Oct;26(2):97-102. doi: 10.1007/s11239-007-0073-1. Epub 2007 Jul 10.
10
Von Willebrand factor in relation to coronary plaque characteristics and cardiovascular outcome. Results of the ATHEROREMO-IVUS study.血管性血友病因子与冠状动脉斑块特征及心血管结局的关系。动脉粥样硬化斑块逆转-血管内超声研究结果
Thromb Haemost. 2015 Mar;113(3):577-84. doi: 10.1160/TH14-07-0589. Epub 2014 Dec 4.

引用本文的文献

1
Alterations in von Willebrand Factor Levels in Patients with Malaria: A Systematic Review and Meta-Analysis of Disease Severity.疟疾患者血管性血友病因子水平的改变:疾病严重程度的系统评价和荟萃分析
Medicina (Kaunas). 2025 Apr 21;61(4):767. doi: 10.3390/medicina61040767.
2
Blood Biomarkers as a Non-Invasive Method for the Assessment of the State of the Fontan Circulation.血液生物标志物作为评估Fontan循环状态的非侵入性方法
J Clin Med. 2025 Jan 14;14(2):496. doi: 10.3390/jcm14020496.
3
Circulating extracellular vesicles as biomarkers in the diagnosis, prognosis and therapy of cardiovascular diseases.

本文引用的文献

1
Detection of coronary artery disease by reduced features and extreme learning machine.基于特征约简和极限学习机的冠状动脉疾病检测
Clujul Med. 2018;91(2):166-175. doi: 10.15386/cjmed-882. Epub 2018 Apr 25.
2
Low dose cadmium upregulates the expression of von Willebrand factor in endothelial cells.低剂量镉上调血管内皮细胞中血管性血友病因子的表达。
Toxicol Lett. 2018 Jun 15;290:46-54. doi: 10.1016/j.toxlet.2018.03.020. Epub 2018 Mar 20.
3
GATA3-induced vWF upregulation in the lung adenocarcinoma vasculature.GATA3诱导肺腺癌脉管系统中血管性血友病因子(vWF)上调。
循环细胞外囊泡作为心血管疾病诊断、预后和治疗中的生物标志物。
Front Cardiovasc Med. 2024 Sep 2;11:1425159. doi: 10.3389/fcvm.2024.1425159. eCollection 2024.
4
Plasma von Willebrand factor levels in patients with cancer: A meta‑analysis.癌症患者的血浆血管性血友病因子水平:一项荟萃分析。
Oncol Lett. 2024 Jun 26;28(2):399. doi: 10.3892/ol.2024.14532. eCollection 2024 Aug.
5
Acquired von Willebrand syndrome and post-operative drainage: a comparison of patients with aortic stenosis versus coronary artery disease.获得性 von Willebrand 综合征与术后引流:主动脉瓣狭窄与冠状动脉疾病患者的比较。
Gen Thorac Cardiovasc Surg. 2024 Aug;72(8):512-518. doi: 10.1007/s11748-023-02007-5. Epub 2024 Jan 27.
6
Predictive value of von Willebrand factor for venous thrombosis in patients with chronic heart failure complicated with atrial fibrillation after anticoagulant therapy.在接受抗凝治疗的慢性心力衰竭合并心房颤动患者中,血管性血友病因子对静脉血栓形成的预测价值。
BMC Cardiovasc Disord. 2023 Jul 13;23(1):349. doi: 10.1186/s12872-023-03167-1.
7
Changes and significance of vascular endothelial injury markers in patients with diabetes mellitus and pulmonary thromboembolism.糖尿病合并肺血栓栓塞症患者血管内皮损伤标志物的变化及意义。
BMC Pulm Med. 2023 May 26;23(1):183. doi: 10.1186/s12890-023-02486-5.
8
Plasma VWF: Ag levels predict long-term clinical outcomes in patients with acute myocardial infarction.血浆血管性血友病因子抗原水平可预测急性心肌梗死患者的长期临床结局。
Front Cardiovasc Med. 2023 Jan 4;9:1013815. doi: 10.3389/fcvm.2022.1013815. eCollection 2022.
9
Coronary Artery Disease and Aortic Valve Stenosis: A Urine Proteomics Study.冠状动脉疾病与主动脉瓣狭窄:尿液蛋白质组学研究。
Int J Mol Sci. 2022 Nov 5;23(21):13579. doi: 10.3390/ijms232113579.
10
The Pharmacological Effects of Silver Nanoparticles Functionalized with Eptifibatide on Platelets and Endothelial Cells.载有依替巴肽的银纳米粒子对血小板和血管内皮细胞的药理作用。
Int J Nanomedicine. 2022 Sep 19;17:4383-4400. doi: 10.2147/IJN.S373691. eCollection 2022.
Oncotarget. 2017 Nov 30;8(66):110517-110529. doi: 10.18632/oncotarget.22806. eCollection 2017 Dec 15.
4
vWF/ADAMTS13 is associated with on-aspirin residual platelet reactivity and clinical outcome in patients with stable coronary artery disease.血管性血友病因子裂解酶(vWF/ADAMTS13)与稳定型冠状动脉疾病患者的阿司匹林抵抗性残余血小板反应性及临床结局相关。
Thromb J. 2017 Nov 22;15:28. doi: 10.1186/s12959-017-0151-3. eCollection 2017.
5
Kinetics of plasma von Willebrand factor in acute myocardial infarction patients: a meta-analysis.急性心肌梗死患者血浆血管性血友病因子的动力学:一项荟萃分析。
Oncotarget. 2017 Aug 9;8(52):90371-90379. doi: 10.18632/oncotarget.20091. eCollection 2017 Oct 27.
6
The Role of von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted Therapy.血管性血友病因子在血管炎症中的作用:从发病机制到靶向治疗
Mediators Inflamm. 2017;2017:5620314. doi: 10.1155/2017/5620314. Epub 2017 May 28.
7
Antiplatelet Therapy Combinations and Thrombogenicity in Patients with Non-Valvular Atrial Fibrillation.非瓣膜性心房颤动患者的抗血小板治疗组合与血栓形成倾向
Korean Circ J. 2017 May;47(3):366-376. doi: 10.4070/kcj.2016.0384. Epub 2017 May 25.
8
Circulating Endothelial Cells and Endothelial Function Predict Major Adverse Cardiac Events and Early Adverse Left Ventricular Remodeling in Patients With ST-Segment Elevation Myocardial Infarction.循环内皮细胞和内皮功能可预测ST段抬高型心肌梗死患者的主要不良心脏事件及早期不良左心室重构。
J Interv Cardiol. 2016 Feb;29(1):89-98. doi: 10.1111/joic.12269.
9
Global burden of CVD: focus on secondary prevention of cardiovascular disease.心血管疾病的全球负担:聚焦于心血管疾病的二级预防。
Int J Cardiol. 2015 Dec;201 Suppl 1:S1-7. doi: 10.1016/S0167-5273(15)31026-3.
10
Plasma von Willebrand factor level is transiently elevated in a rat model of acute myocardial infarction.在急性心肌梗死大鼠模型中,血浆血管性血友病因子水平会短暂升高。
Exp Ther Med. 2015 Nov;10(5):1743-1749. doi: 10.3892/etm.2015.2721. Epub 2015 Sep 1.